Major Editorial Projects

Time • May 2 2024

Mulikat Okanlawon and Fidel Strub: Noma heroes

No one knows for sure how many people die each year from a disease called noma, which causes a gangrenous infection on the face, because it’s not well researched or tracked. In 1998, the last year from which data is available, 140,000 people developed it and 90% died, according to the WHO. The disease affects the world’s most vulnerable people: 2- to 6-year-old children, especially those who are malnourished or in extreme poverty. Its final stage kills within a few days. Survivors are severely d

Time • April 29 2024

The Best Companies for Future Leaders

How TIME and Statista Determined the Best Colleges and Companies for Future Leaders

Americans often envision themselves climbing the corporate ladder within one company to rise into leadership. But today, getting to the c-suite is more often a matter of “building your brand” and moving from company to company, says Peter Cappelli, professor of management at The Wharton School. “Companies are not hiring for potential much anymore,” he says. “There’s an awful lot of lateral movement.”

But certai

Time • February 8 2024

Karim Beguir Wants to Empower the World With AI

For an industry that trades on newness, tech can be remarkably staid. Many of the big players are headquartered in a Northern California valley, and world-changing innovations are often produced by goliaths like Apple and Google. In just a decade, however, decision-making AI company InstaDeep has challenged that status quo. Led by co-founder and CEO Karim Beguir, the company set up shop in Tunis, far from the Bay Area’s tech bubble. InstaDeep also operates in a complex domain: deep tech, meaning

Photo by Pixabay on Pexels

Time • October 24 2023

Improved Cavity Access Machine: The 200 Best Inventions of 2023

While the U.S. has long urged other countries to destroy their chemical weapon stockpiles, it didn’t eliminate the last of its mustard gas mortars until this summer. Part of the problem was that decades-old liquid mustard had coagulated into a “greasy, tar-like substance,” says James DeSmet, the CEO of CRG Automation. In less than two years, however, a team that included CRG cleansed the weapons with a robotic system it designed and constructed, the Improved Cavity Access Machine, which disassemb

Photo by Public Domain Pictures on Pexels

Time • September 13 2023

2023 TIME100 Next: Laura Modi and Sarah Hardy

A handful of producers have dominated the American baby-formula industry for decades, and the industry isn’t known for being on the cutting edge. But after Laura Modi and Sarah Hardy had children, they found they were dissatisfied with the options. They turned that frustration into a company, Bobbie, which touts that it follows not only the infant-formula standards set by the FDA, but also those of the European Union, and is both USDA- and E.U.-certified organic. They’ve made a splash in the marke

Photo by Michael Tuszynski on Pexels

Time • September 13 2023

2023 TIME100 Next: Wemimo Abbey and Samir Goel

Wemimo Abbey’s and Samir Goel’s families faced many obstacles after immigrating to the U.S., including limited access to credit. Those challenges helped inspire a smart idea to help others in similar straits. In 2018, the pair founded Esusu, which helps people build credit in America by reporting tenants’ on-time rent payments to credit bureaus.

Esusu has helped over 50,000 people establish credit scores, the company says. These records are a lifeline that can be used to buy cars, access mortgag

Photo by Pixabay on Pexels

Time • September 13 2023

2023 TIME100 Next: Nabarun Dasgupta

Few Americans have done more to prevent drug–overdose deaths than Nabarun Dasgupta. In the past few years, the scientist at the University of North Carolina’s Gillings School of Global Public Health helped launch a program through the nonprofit Remedy Alliance that cleared bottlenecks stopping the opioid-overdose-reversing drug naloxone from getting to the front lines. After creating new supply arrangements and buying the treatment in bulk, the organization distributed over 1.6 million doses acro

Photo by Ksenia Chernaya on Pexels

Time • June 21 2023

TIME100 Most Influential Companies 2023: Lexie Hearing

Millions of Americans who could benefit from hearing aids don’t use them because of issues like stigma and cost, so when the FDA approved over-the-counter sales of hearing devices for the first time in 2022, experts hailed it as an opportunity to expand access and save customers thousands of dollars. A shrewd partnership with Bose and distribution in 12,000 stores across the U.S. helped hearing-aid maker Lexie Hearing leap ahead of the pack. It now expects to earn $60 million in revenue and expan